CVC is a leading global private equity firm that manages over €193 billion of AUM, and has a strong investment track record in the healthcare industry across Europe and other key global markets. PharmaResearch aims to leverage CVC’s extensive Asian and ...
Total AUM of €193bn including CVC DIF Continued diversification of the Group: Secondaries, Credit and Infrastructure now represent c.46% of total FPAUM Increase in H1 2024 deployment activity: +63% to €13.4bn vs. H1 2023, primarily driven by a significant increase in Private Equity investing...
In 2022, CVC announced that it had invested inVietnam’s Phuong Chau Healthcare Group, which operates a chain of private hospitals in the country’s southern provinces. One year later, the private equity firm closed on its purchase of a majority stake inGuam-based hospital group The Medical ...
Get real-time CVC Limited (CVC) stock price, overview, news, and analysis. Set real-time notifications to track company news and stock price changes.
1. Acquisition of CVC DIF signed in September 2023 and completed on 1 July 2024. Europe / Americas Fund IX, Asia VI and Strategic Opportunities III were each activated on 3 May 2024, at the earlier end of the mid-2024 guidance. Strategic Opportunities III is not included in FPAUM given ...
Investors in CVC Credit benefit greatly from shared research and analysis informed by the history, knowledge and global reach of the wider CVC Network. CVC's private equity platform currently manages €119 billion of assets and has completed over330 equity investmentsacross many different sectors and...
(2) Average FPAUM of Private Equity Funds are calculated based on committed capital or invested capital on a daily basis. Average FPAUM of Secondaries Funds are calculated based on committed capital on a quarterly basis. Average FPAUM of Credit vehicles are calculated based on invested capital ...